What amount sold does Pleural Dynamics, Inc. report in Form D filings?

The latest linked filings report $9.2M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Pleural Dynamics, Inc.'s most recent SEC filing?

Pleural Dynamics, Inc.'s most recent Form D filing was on 2025-11-18.

How many investors does Pleural Dynamics, Inc. have?

The most recent Form D filing lists 6 investor(s).

What type of securities does Pleural Dynamics, Inc. offer?

Pleural Dynamics, Inc.'s SEC Form D filings indicate debt offerings.

Pleural Dynamics, Inc.

CIK: 0001812981·Biotechnology·Wayzata, MN·Corporation

Reported Sold

$9,163,767

Total Filings

Identified Offerings

Last Filed

Nov 18, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Nov 18, 2025Form D — New notice

Reported sold: $618,000 · Target: $4,000,000

Rule 506(b)·6 investors

Feb 4, 2025Form D/A — Amendment

Reported sold: $7,710,767 · Target: $8,521,054

Rule 506(b)·29 investors

Changed: Reported amount sold, Offering target, Reported investors

Dec 10, 2024Form D/A — Amendment

Reported sold: $5,463,239 · Target: $8,361,023

Rule 506(b)·28 investors

Changed: Reported amount sold, Offering target

Mar 5, 2024Form D/A — Amendment

Reported sold: $4,485,864 · Target: $5,103,360

Rule 506(b)·28 investors

Changed: Reported amount sold, Offering target, Reported investors

May 25, 2023Form D — New notice

Reported sold: $3,683,286 · Target: $5,638,562

Rule 506(b)·22 investors

May 22, 2020Form D — New notice

Reported sold: $835,000 · Target: $1,250,000

Rule 506(b)·10 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 3 identified offerings

$9,163,767

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Martin L. Mayse

Related Person

Appears on 5 filings

Mark Deem

Related Person

Appears on 5 filings

Robert Crutchfield

Related Person

Appears on 4 filings

Gintaras Vaisnys

Related Person

Appears on 2 filings

Richard Stark

Related Person

Appears on 2 filings

Martin Mayse

Related Person

Appears on 1 filing

Amy Salzhauer

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 18, 2025	New	$4,000,000	$618,000	6
Feb 4, 2025	Amendment	$8,521,054	$7,710,767	29
Dec 10, 2024	Amendment	$8,361,023	$5,463,239	28
Mar 5, 2024	Amendment	$5,103,360	$4,485,864	28
May 25, 2023	New	$5,638,562	$3,683,286	22
May 22, 2020	New	$1,250,000	$835,000	10

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

InSitu Biologics, Inc.

Biotechnology

Offering target: $3,375,000

Filed Oct 14, 2026